Page last updated: 2024-09-03

silahexocyclium and methoctramine

silahexocyclium has been researched along with methoctramine in 1 studies

Compound Research Comparison

Studies
(silahexocyclium)
Trials
(silahexocyclium)
Recent Studies (post-2010)
(silahexocyclium)
Studies
(methoctramine)
Trials
(methoctramine)
Recent Studies (post-2010) (methoctramine)
60040015

Protein Interaction Comparison

ProteinTaxonomysilahexocyclium (IC50)methoctramine (IC50)
CholinesteraseHomo sapiens (human)0.9772
Muscarinic acetylcholine receptor M2Homo sapiens (human)0.0407
AcetylcholinesteraseHomo sapiens (human)5.3703
Glutamate receptor ionotropic, NMDA 1Homo sapiens (human)0.138
Glutamate receptor ionotropic, NMDA 2AHomo sapiens (human)0.138
Carboxylic ester hydrolase Rattus norvegicus (Norway rat)0.9772

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bonner, TI; Brann, MR; Buckley, CM; Buckley, NJ1

Other Studies

1 other study(ies) available for silahexocyclium and methoctramine

ArticleYear
Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
    Molecular pharmacology, 1989, Volume: 35, Issue:4

    Topics: Animals; Cell Line; Cloning, Molecular; Cricetinae; Humans; Kinetics; N-Methylscopolamine; Parasympatholytics; Rats; Receptors, Muscarinic; Scopolamine Derivatives

1989